Chemoinformaics analysis of 1-Methyl-6-oxo-1,6-dihydropyridine-3-carbonitrile
| Molecular Weight | 134.138 | nRot | 0 |
| Heavy Atom Molecular Weight | 128.09 | nRig | 8 |
| Exact Molecular Weight | 134.048 | nRing | 1 |
| Solubility: LogS | -0.396 | nHRing | 1 |
| Solubility: LogP | -0.067 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 18.6928 |
| nHD | 0 | BPOL | 9.16724 |
| QED | 0.51 |
| Synth | 2.389 |
| Natural Product Likeliness | -1.465 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.591 |
| MDCK | 0.0000237 |
| BBB | 0.45 |
| PPB | 0.20876 |
| VDSS | 0.824 |
| FU | 0.731835 |
| CYP1A2-inh | 0.515 |
| CYP1A2-sub | 0.942 |
| CYP2c19-inh | 0.046 |
| CYP2c19-sub | 0.23 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.308 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.412 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.481 |
| CL | 6.264 |
| T12 | 0.809 |
| hERG | 0.028 |
| Ames | 0.23 |
| ROA | 0.406 |
| SkinSen | 0.144 |
| Carcinogencity | 0.877 |
| EI | 0.804 |
| Respiratory | 0.054 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.824735 |